CRISPR Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Switzerland · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Baarerstrasse 14, Zug, Zug, 6300, Switze...Phone Number
+41 415613277Website
www.crisprtx.comRevenue
$11 MillionStock Symbol
CRSPIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About CRISPR Therapeutics
Crispr Therapeutics, founded in 2013 and headquartered in Zug, Switzerland, is a developer of gene-based medications that target diseases at the molecular level.Explore more
CRISPR Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CRISPR Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at CRISPR Therapeutics
Check if CRISPR Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if CRISPR Therapeutics is spiking on competitors!
CRISPR Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once CRISPR Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when CRISPR Therapeutics launches new products
Click to see if CRISPR Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on CRISPR Therapeutics recently announced quarterly report
Recommended Actions
Find VP level buyers at CRISPR Therapeutics
Find 3 more new buyers
Company Profile Activity
Activity Insights
CRISPR Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CRISPR Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CRISPR Therapeutics.
CRISPR Therapeutics financials insights
Gather financial insights about CRISPR Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Stock Offering
$56M
CRISPR Therapeutics Tech Stack
A closer look at the technologies used by CRISPR Therapeutics
See more technologies
Most Recent Scoops
Open Position
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Hiring Plans
CRISPR Therapeutics has more open roles in Engineering & Technical than it has had at any time in the past 12 months.
Hiring Plans
Open Position
CRISPR Therapeutics News & Media
AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie is profitable, growing, and paying a rising dividend. CRISPR is burning cash in pursuit of a gene-editing breakthrough that could reshape medicine.Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
One company is generating billions in revenue and raising its dividend. The other is burning cash in pursuit of a scientific breakthrough that could change how diseases are treated.Axsome Therapeutics vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
One company is scaling revenue rapidly but burning cash; the other is pioneering gene therapy with minimal sales and massive losses.Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in September
Both companies are approaching milestones that could light a fire under their stocks.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CRISPR Therapeutics
Sign Up For FreeTo access detailed company insights
Crispr Therapeutics, founded in 2013 and headquartered in Zug, Switzerland, is a developer of gene-based medications that target diseases at the molecular level.... Read More
